Schütz E - Search Results

1

Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites.

Schütz E, Shipkova M, Armstrong VW, Niedmann PD, Weber L, Tönshoff B, Pethig K, Wahlers T, Braun F, Ringe B, Oellerich M. Schütz E, et al. Transplant Proc. 1998 Jun;30(4):1185-7. doi: 10.1016/s0041-1345(98)00201-2. Transplant Proc. 1998. PMID: 9636479 No abstract available.

2

Haptoglobin as a sensitive marker of hemolysis in HELLP-syndrome.

Wilke G, Rath W, Schutz E, Armstrong VW, Kuhn W. Wilke G, et al. Among authors: schutz e. Int J Gynaecol Obstet. 1992 Sep;39(1):29-34. doi: 10.1016/0020-7292(92)90776-f. Int J Gynaecol Obstet. 1992. PMID: 1358701

3

Lack of association between raised serum Lp(a) concentration and unsuccessful thrombolysis after acute myocardial infarction.

Armstrong VW, Neubauer C, Schütz E, Tebbe U. Armstrong VW, et al. Among authors: schutz e. Lancet. 1990 Oct 27;336(8722):1077. doi: 10.1016/0140-6736(90)92557-x. Lancet. 1990. PMID: 1977059 No abstract available.

4

Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP).

Schuff-Werner P, Schütz E, Seyde WC, Eisenhauer T, Janning G, Armstrong VW, Seidel D. Schuff-Werner P, et al. Among authors: schutz e. Eur J Clin Invest. 1989 Feb;19(1):30-7. doi: 10.1111/j.1365-2362.1989.tb00192.x. Eur J Clin Invest. 1989. PMID: 2499459

5

Long-term clinical experience with HELP-LDL-apheresis in combination with HMG-CoA-reductase inhibitors for maximum treatment of coronary heart disease associated with severe hypercholesterolemia.

Eisenhauer T, Armstrong VW, Schuff-Werner P, Schütz E, Thiery J, Scheler F, Seidel D. Eisenhauer T, et al. Among authors: schutz e. ASAIO Trans. 1989 Jul-Sep;35(3):580-3. doi: 10.1097/00002480-198907000-00133. ASAIO Trans. 1989. PMID: 2597539

6

Metabolic liver function and lipoprotein metabolism after orthotopic liver transplantation in patients on immunosuppressive therapy with FK 506 or cyclosporine.

Armstrong VW, Kaltefleiter M, Luy-Kaltefleiter M, Schütz E, Wieland E, Loss M, Winkler M, Ringe B, Oellerich M. Armstrong VW, et al. Among authors: schutz e. Transplant Proc. 1995 Feb;27(1):1201-3. Transplant Proc. 1995. PMID: 7533371 Clinical Trial. No abstract available.

7

Relationship of apolipoproteins AI, B and lipoprotein Lp(a) to hepatic function of liver recipients during the early post-transplant period.

Armstrong VW, Schütz E, Kaltefleiter M, Luy M, Helmhold M, Wieland E, Ringe B, Oellerich M. Armstrong VW, et al. Among authors: schutz e. Eur J Clin Invest. 1995 Jul;25(7):485-93. doi: 10.1111/j.1365-2362.1995.tb01734.x. Eur J Clin Invest. 1995. PMID: 7556366

8

Monoethylglycinexylidide as an early predictor of posttraumatic multiple organ failure.

Lehmann U, Armstrong VW, Schütz E, Regel G, Pape D, Oellerich M. Lehmann U, et al. Among authors: schutz e. Ther Drug Monit. 1995 Apr;17(2):125-32. doi: 10.1097/00007691-199504000-00004. Ther Drug Monit. 1995. PMID: 7624899

9

Idebenone protects hepatic microsomes against oxygen radical-mediated damage in organ preservation solutions.

Wieland E, Schütz E, Armstrong VW, Küthe F, Heller C, Oellerich M. Wieland E, et al. Among authors: schutz e. Transplantation. 1995 Sep 15;60(5):444-51. doi: 10.1097/00007890-199509000-00007. Transplantation. 1995. PMID: 7676491

10

Azathioprine myelotoxicity related to elevated 6-thioguanine nucleotides in heart transplantation.

Schütz E, Gummert J, Mohr FW, Armstrong VW, Oellerich M. Schütz E, et al. Transplant Proc. 1995 Feb;27(1):1298-300. Transplant Proc. 1995. PMID: 7878889 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters